158 related articles for article (PubMed ID: 10779450)
1. Quantitative measure of c-abl and p15 methylation in chronic myelogenous leukemia: biological implications.
Nguyen TT; Mohrbacher AF; Tsai YC; Groffen J; Heisterkamp N; Nichols PW; Yu MC; Lübbert M; Jones PA
Blood; 2000 May; 95(9):2990-2. PubMed ID: 10779450
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility of nonpromoter CpG islands to de novo methylation in normal and neoplastic cells.
Nguyen C; Liang G; Nguyen TT; Tsao-Wei D; Groshen S; Lübbert M; Zhou JH; Benedict WF; Jones PA
J Natl Cancer Inst; 2001 Oct; 93(19):1465-72. PubMed ID: 11584062
[TBL] [Abstract][Full Text] [Related]
3. Detailed mapping of methylcytosine positions at the CpG island surrounding the Pa promoter at the bcr-abl locus in CML patients and in two cell lines, K562 and BV173.
Fajkusová L; Fajkus J; Polácková K; Fulnecek J; Dvoráková D; Krahulcová E
Blood Cells Mol Dis; 2000 Jun; 26(3):193-204. PubMed ID: 10950939
[TBL] [Abstract][Full Text] [Related]
4. DNA hypermethylation of cell cycle (p15 and p16) and apoptotic (p14, p53, DAPK and TMS1) genes in peripheral blood of leukemia patients.
Bodoor K; Haddad Y; Alkhateeb A; Al-Abbadi A; Dowairi M; Magableh A; Bsoul N; Ghabkari A
Asian Pac J Cancer Prev; 2014; 15(1):75-84. PubMed ID: 24528084
[TBL] [Abstract][Full Text] [Related]
5. ABL1 promoter methylation can exist independently of BCR-ABL transcription in chronic myeloid leukemia hematopoietic progenitors.
Sun B; Jiang G; Zaydan MA; La Russa VF; Safah H; Ehrlich M
Cancer Res; 2001 Sep; 61(18):6931-7. PubMed ID: 11559572
[TBL] [Abstract][Full Text] [Related]
6. Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells.
Drexler HG
Leukemia; 1998 Jun; 12(6):845-59. PubMed ID: 9639410
[TBL] [Abstract][Full Text] [Related]
7. Expression of DNA methyltransferases DNMT1, 3A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemia.
Mizuno S; Chijiwa T; Okamura T; Akashi K; Fukumaki Y; Niho Y; Sasaki H
Blood; 2001 Mar; 97(5):1172-9. PubMed ID: 11222358
[TBL] [Abstract][Full Text] [Related]
8. p14ARF, p15INK4b and p16INK4a methylation status in chronic myelogenous leukemia.
Kusy S; Larsen CJ; Roche J
Leuk Lymphoma; 2004 Oct; 45(10):1989-94. PubMed ID: 15370242
[TBL] [Abstract][Full Text] [Related]
9. Progressive de novo DNA methylation at the bcr-abl locus in the course of chronic myelogenous leukemia.
Zion M; Ben-Yehuda D; Avraham A; Cohen O; Wetzler M; Melloul D; Ben-Neriah Y
Proc Natl Acad Sci U S A; 1994 Oct; 91(22):10722-6. PubMed ID: 7938018
[TBL] [Abstract][Full Text] [Related]
10. ABL1 methylation is a distinct molecular event associated with clonal evolution of chronic myeloid leukemia.
Asimakopoulos FA; Shteper PJ; Krichevsky S; Fibach E; Polliack A; Rachmilewitz E; Ben-Neriah Y; Ben-Yehuda D
Blood; 1999 Oct; 94(7):2452-60. PubMed ID: 10498618
[TBL] [Abstract][Full Text] [Related]
11. p14ARF, p15INK4b, and p16INK4a methylation status in chronic myelogenous leukemia.
Kusy S; Cividin M; Sorel N; Brizard F; Guilhot F; Brizard A; Larsen C; Roche J
Blood; 2003 Jan; 101(1):374-5. PubMed ID: 12485942
[No Abstract] [Full Text] [Related]
12. Expression of cell cycle regulatory genes in chronic myelogenous leukemia.
Iolascon A; Della Ragione F; Giordani L; Serra A; Saglio G; Faienza MF
Haematologica; 1998 Sep; 83(9):771-7. PubMed ID: 9825572
[TBL] [Abstract][Full Text] [Related]
13. p15(INK4B) CpG island methylation in primary acute leukemia is heterogeneous and suggests density as a critical factor for transcriptional silencing.
Cameron EE; Baylin SB; Herman JG
Blood; 1999 Oct; 94(7):2445-51. PubMed ID: 10498617
[TBL] [Abstract][Full Text] [Related]
14. [P15(INK4B) gene methylation in malignant hematopoietic diseases].
Wu Q; Guo X; Fan H; Zhou T; Tan G; Guo Q; Chen P; Zhang X; Luo G; Xu M
Zhonghua Xue Ye Xue Za Zhi; 2000 Dec; 21(12):644-6. PubMed ID: 11877040
[TBL] [Abstract][Full Text] [Related]
15. Hypermethylation of p16 and p15 genes and RB protein expression in acute leukemia.
Guo SX; Taki T; Ohnishi H; Piao HY; Tabuchi K; Bessho F; Hanada R; Yanagisawa M; Hayashi Y
Leuk Res; 2000 Jan; 24(1):39-46. PubMed ID: 10634644
[TBL] [Abstract][Full Text] [Related]
16. P53, p15INK4B, p16INK4A and p57KIP2 mutations during the progression of chronic myeloid leukemia.
Güran S; Bahçe M; Beyan C; Korkmaz K; Yalçin A
Haematologia (Budap); 1998; 29(3):181-93. PubMed ID: 10069444
[TBL] [Abstract][Full Text] [Related]
17. Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2'-deoxycytidine (decitabine) treatment.
Daskalakis M; Nguyen TT; Nguyen C; Guldberg P; Köhler G; Wijermans P; Jones PA; Lübbert M
Blood; 2002 Oct; 100(8):2957-64. PubMed ID: 12351408
[TBL] [Abstract][Full Text] [Related]
18. Methylation of the p15(INK4b) gene in myelodysplastic syndromes is frequent and acquired during disease progression.
Quesnel B; Guillerm G; Vereecque R; Wattel E; Preudhomme C; Bauters F; Vanrumbeke M; Fenaux P
Blood; 1998 Apr; 91(8):2985-90. PubMed ID: 9531610
[TBL] [Abstract][Full Text] [Related]
19. Aberrant p15 promoter methylation in adult and childhood acute leukemias of nearly all morphologic subtypes: potential prognostic implications.
Wong IH; Ng MH; Huang DP; Lee JC
Blood; 2000 Mar; 95(6):1942-9. PubMed ID: 10706859
[TBL] [Abstract][Full Text] [Related]
20. Expression of p15(INK4B) in hematopoietic progenitors.
Teofili L; Larocca LM; Leone G
Haematologica; 1999; 84(E-letters):E01. PubMed ID: 11084659
[No Abstract] [Full Text] [Related]
[Next] [New Search]
